BAY-3389934
- Generic Name
- BAY-3389934
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT06854640
- Locations
- 🇧🇪
UZ Antwerpen - Intensive Care, Edegem, Belgium
🇧🇪Centre Hospitalier Universitaire (CHU) de Liege - Domaine Universitaire du Sart Tilman - Intensive Care, Liege, Belgium
🇧🇪Clinique Saint-Pierre d'Ottignies - Intensive Care, Ottignies-Louvain-La-Neuve, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath